Abstract:Background: Obesity is a risk factor for cardiovascular diseases; however, in obese heart failure (HF) patients live longer than lean HF patients, this observation is known as obesity paradox. MicroRNAs (miRs) regulate processes involved in both cardiac remodeling and obesity. Objective: We investigated whether the levels of circulating miRs in HF patients are influenced by obesity. Methods: In this case–control study, twenty HF patients (10 obese and 10 lean) and 10 healthy control individuals were analyzed using Affymetrix GeneChip miRNA 4.0 Array following manufacturer's instruction. Raw data was normalized using the Robust Multiarray Average method, batch effect was adjusted with Surrogate Variable Analysis, pairwise differential expression analysis was carry-out with Limma R package, and miRPath v3.0 was used to interrogate pathways enriched for the dysregulated miRNAs based on validated targets from Tarbase v7.0 and KEGG pathways annotation database. Bioinformatics and statistical analysis were performed using R and a p-value <0.01 was considered significant. Results and conclusions: We discovered a set of 36 and 48 miRNAs that were differentially expressed in obese HF and lean HF, respectively, in relation to controls. Thirteen miRNAs were commonly dysregulated in both HF groups. In addition, we found hsa-miR-451a to be up-regulated in obese HF in relation to controls, as well as to lean HF patients, suggesting that obesity may accentuate its dysregulation. On the other hand, hsa-miR-4738-5p, hsa-miR-1260a, and hsa-miR-98-5p were differentially expressed in lean HF in relation to both remaining groups. Pathways enrichment analysis suggested that hsa-miR-451a regulates genes from the mTOR signaling pathway (p=0.002), whereas hsa-miR-1260a modulates Hippo (p=0.02) and AMPK (p=0.03) signaling pathways, all of which have been previously related to cardiac hypertrophy. Further investigation and validation of their targets may contribute to a better understanding of the obesity paradox.

Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage

MicroRNA and obesity

A New Insight into the Roles of MiRNAs in Metabolic Syndrome

Role of MicroRNAs in Obesity-Induced Metabolic Disorder and Immune Response

MicroRNAs: Emerging Roles in Adipogenesis and Obesity.

Abstract 943: Circulating Mirnome in Obese and Lean Heart Failure Patients: A Case-control Study

MicroRNAs as Epigenetic Regulators of Obesity

The Clinical Potential of Circulating Micrornas in Obesity

Effects of Polycystic Ovary Syndrome (PCOS), Sex Hormones, and Obesity on Circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 Expression

Role of MicroRNAs in Dietary Interventions for Obesity and Obesity-Related Diseases.

Novel Interactions Between Circulating microRNAs and Gut Microbiota Composition in Human Obesity.

A multi-omics census reveals obesity-associated microRNA miR-let-7 as novel instigator of adipose mitochondrial dysfunction and of intergenerational metabolic decline.

An Integrated Analysis of miRNA and Gene Expression Changes in Response to an Obesogenic Diet to Explore the Impact of Transgenerational Supplementation with Omega 3 Fatty Acids

Cardiovascular Disease and miRNAs: Possible Oxidative Stress-Regulating Roles of miRNAs

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease

MicroRNA Regulated Macrophage Activation in Obesity.

MicroRNAs in metabolic dysfunction-associated diseases: Pathogenesis and therapeutic opportunities

microRNA and the Post-Transcriptional Response to Oxidative Stress during Neuronal Differentiation: Implications for Neurodevelopmental and Psychiatric Disorders

microRNA Expression Profile in Obesity-Induced Kidney Disease Driven by High-Fat Diet in Mice

miRNAs as Interconnectors between Obesity and Cancer

Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.